[
    [
        {
            "time": "2018-09-12",
            "original_text": "格隆汇港股聚焦(9.12)︱众安在线前8月原保费收入增近两成 复宏汉霖将于9月25日登陆港交所",
            "features": {
                "keywords": [
                    "众安在线",
                    "原保费收入",
                    "增长",
                    "复宏汉霖",
                    "上市",
                    "港交所"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "保险",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(9.12)︱众安在线前8月原保费收入增近两成 复宏汉霖将于9月25日登陆港交所",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "上海医药(601607.SH)：上实集团于9月12日增持20.55万股H股",
            "features": {
                "keywords": [
                    "上海医药",
                    "上实集团",
                    "增持",
                    "H股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)：上实集团于9月12日增持20.55万股H股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2018-09-12",
            "original_text": "上海医药(02607.HK)控股股东上实集团增持20.55万股H股",
            "features": {
                "keywords": [
                    "上海医药",
                    "上实集团",
                    "控股股东",
                    "增持",
                    "H股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)控股股东上实集团增持20.55万股H股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        }
    ]
]